These findings suggest that the PPRE binding activity of PPARα deteriorated due to the development of anti-Thy1 nephritis in the control group; however, the pretreatment with clofibrate outweighed this deterioration and continuously activated glomerular PPARα. This evidence concerns the gene PPARA and nephritis.